News for DECN Stock

DECN Announces Completion of Critical Instructional Videos for its GenViro! Saliva Swift Kit for USA and International Professional Use DECN Announces Finalizing of International Genviro! COVID-19 Saliva Swift Kits for Global Market and Establishes Introductory Sales Pricing DECN Enters into an Additional 6 Month $300,000 Promissory Note With Major Current Investor to Further Assist Launch of Genviro Swift Kits for the Detection of the Covid-19 Virus DECN to Launch Its International Version GenViro! Saliva Swift :10.5 Second Covid-19 Kits on September 26, Will Then Accept Orders from Its Asian Distributor DECN Provides Update on Accomplishments and Pathway to Securing FDA EUA Approval for its COVID-19 "Transmission Indicating Testing" Methodology DECN CEO Releases Open Letter on FDA At-Home COVID-19 Rapid Testing Guidelines Saying It's the Speed to Results Reporting and Certain Added Regulations That Need to Be Addressed DECN Announces Significant Agreement With Russian Federation Partner for Genviro! and Genviro! Pro COVID-19 Testing Kits as Well as Its Venerable GenUltimate! Blood Glucose Products DECN XPRIZE Testing Data for Rapid COVID-19 Testing Technology Yields Near Textbook Results DECN Announces Additional Distribution Agreement With a Distributor and Dealers in Nigeria, Ivory Coast and Lebanon DECN Announces Commencement of US-Based Donor Study for FDA EUA Guidance Testing for Their 10.5 Second Genviro! Saliva Swift COVID-19 Test Kits DECN Provides Progress Update on Major Events for Its GenViro! Saliva Swift Kits for the Detection of COVID-19 DECN Enters into a New 6 Month $300,000 Promissory Note with Major Current Investor to Help Fund the Recent International Launch if its GenViro! Swift Kits DECN Receives Significant Initial Order for International GenViro! Saliva Swift Kits for the Detection of COVID-19 DECN Signs Agreement With US-Based Laboratory as Testing Partner for Genviro! Saliva Swift Kit Testing for Additional FDA, EU CE Mark and Russian Federation Submissions